The nephrotoxicity of bortezomib: did we miss a complication after 20 years of use and multiple landmark trials?

Raad B. Chowdhury; Efstathios Kastritis; S. Vincent Rajkumar; Nelson Leung

doi:10.1093/ndt/gfad061

The nephrotoxicity of bortezomib: did we miss a complication after 20 years of use and multiple landmark trials?

Raad B. Chowdhury, Efstathios Kastritis, S. Vincent Rajkumar, Nelson Leung

Hematology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	2099-2104
Number of pages	6
Journal	Nephrology Dialysis Transplantation
Volume	38
Issue number	10
DOIs	https://doi.org/10.1093/ndt/gfad061
State	Published - Oct 1 2023

ASJC Scopus subject areas

Nephrology
Transplantation

Access to Document

10.1093/ndt/gfad061

Cite this

@article{76bc5a10562c4d5a821501691d1551a1,

title = "The nephrotoxicity of bortezomib: did we miss a complication after 20 years of use and multiple landmark trials?",

author = "Chowdhury, {Raad B.} and Efstathios Kastritis and Rajkumar, {S. Vincent} and Nelson Leung",

year = "2023",

month = oct,

day = "1",

doi = "10.1093/ndt/gfad061",

language = "English (US)",

volume = "38",

pages = "2099--2104",

journal = "Nephrology Dialysis Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - The nephrotoxicity of bortezomib

T2 - did we miss a complication after 20 years of use and multiple landmark trials?

AU - Chowdhury, Raad B.

AU - Kastritis, Efstathios

AU - Rajkumar, S. Vincent

AU - Leung, Nelson

PY - 2023/10/1

Y1 - 2023/10/1

UR - http://www.scopus.com/inward/record.url?scp=85174516889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85174516889&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfad061

DO - 10.1093/ndt/gfad061

M3 - Editorial

C2 - 37002539

AN - SCOPUS:85174516889

SN - 0931-0509

VL - 38

SP - 2099

EP - 2104

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

IS - 10

ER -

The nephrotoxicity of bortezomib: did we miss a complication after 20 years of use and multiple landmark trials?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this